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Nitric oxide in acute renal failure: NOS versus NOS. This ation of NO by iNOS, depending on the cellular context,
overview provides information on the pathophysiology of the may turn on a broad spectrum of sequelae, from anti-
inducible nitric oxide synthase/nitric oxide (iNOS/NO) system apoptotic action, to lipid peroxidation, DNA damage andin the injury to cultured renal tubular epithelia, freshly isolated
pro-apoptotic effects [3]. In addition, we shall illustrateproximal tubules, and the whole organ after hypoxic or isch-
how the imperfection of our models of acute renal injuryemic insult. The findings emphasize the role of concomitant
oxidative and nitrosative stress and the role of peroxynitrite in has hindered, and continues to do so, the elucidation of
the ensuing renal dysfunction. Scavenging peroxynitrite using the role played by NO in renal response to stressors.
seleno-organic compounds like ebselen provides renoprotec-
tion against ischemic injury. These sequelae of renal ischemia
are a result of endothelial dysfunction, which is most probably EFFECTS OF SELECTIVE ANDresponsible for the “no-reflow” phenomenon and further ag-
NON-SELECTIVE NOS INHIBITORS:gravation of tubular ischemia during the early reperfusion pe-
LESSONS LEARNEDriod. Recent studies have demonstrated that transplantation
of functional endothelial cells into ischemic kidney provided Yu et al demonstrated that a general NOS inhibitor
a dramatic renoprotective effect. In conclusion, the intricate
prevented hypoxic cellular damage in freshly preparedrelations between endothelial and epithelial cells, based in part
proximal tubules [4]. Further, Peresleni et al showed thaton the relations between endothelial and inducible nitric oxide
synthases, are perturbed in renal ischemia primarily as a result oxidant stress to epithelial BSC-1 cells resulted in in-
of endothelial dysfunction precipitating epithelial injury. creased immunodetectable iNOS, elevated NO release
and nitrite production, and decreased cell viability [5].
All things come to pass according to conflict. When BSC-1 cells were transfected with an antisense oli-
Heraclitus godeoxynucleotide (AS-ODN) to iNOS, this treatment
abrogated elevation in nitrite production, reduced the
This brief review focuses on the imbalance between the intensity of immunocytochemical and nicotinamide ade-
expression and activity of the inducible and constitutive nine dinucleotide phosphate (NADPH) diaphorase stain-
endothelial isoforms of nitric oxide synthase (NOS) be- ing, as well as prevented lethal cell damage. In parallel,
ing an important contributor to the pathophysiology of staining with antibodies to nitrotyrosine, conspicuous in
acute renal failure. This view is based on the heterogene- stressed cells, was undetectable in AS-ODN-treated cells.
ity of the effects of nitric oxide (NO) depending on the These data support the possibility of NO conversion to
site of its production, both within the cell and within peroxynitrite during oxidative stress and implicate it in
the nephron, duration of its effect, and the concomitant cytotoxicity to BSC-1 cells [6–8].
presence of reactive oxygen intermediates (ROI). The Several lines of evidence suggest the possible link be-
existing vast database on the functional consequences of tween oxidant stress and NO production. It has been dem-
variations in these parameters is summarized in Figure 1 onstrated that both the myocardial reoxygenation [9]
(effects of NO). Transient spike-like generation of NO, and cerebral ischemia and reperfusion [10] result in the
characteristic of endothelial NOS (eNOS) activation [1]
increased generation of NO. The mechanism(s) mediat-
is critical for turning on several heme-containing en-
ing induction of iNOS after exposure to oxidant stress
zymes, such as soluble guanylate cyclase, mediation of
remain unknown. It has recently been hypothesized thatvasorelaxation, anti-apoptotic program and protection
cytotoxic sequelae of NO production depend on the re-against oxidative stress [2]. Sustained, high-output gener-
dox state of the cell and its ability to generate peroxy-
nitrite (ONOO) anion [7]. The data presented herein
indicate that the up-regulation of NOS is associated withKey words: renal ischemia, peroxynitrite, oxidative and nitrosative
stress, endothelial dysfunction, ischemia, renoprotection. cytotoxicity of oxidant stress, and implicate the iNOS in
this response, as cartooned in Figure 2A. 2002 by the International Society of Nephrology
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Fig. 1. Cellular effects of nitric oxide (NO)
depend on its concentration, site of release
and duration of action. Abbreviations are:
NOS, nitric oxide synthase; ROI, reactive oxy-
gen intermediates; GC, guanylate cyclase.
Fig. 2. Evolution of our understanding of the involvement of NO and sites of its generation on renal injury. (A) Effects limited to the isolated
epithelial cells. (B) The role of peroxynitrite and its potential sources in epithelial cell injury. (C) Involvement of eNOS and NO bioavailability
in the subsequent development of injury to the proximal epithelial cells. Abbreviations are: NO, nitric oxide, iNOS, inducible nitric oxide
synthase; eNOS, endothelial nitric oxide synthase; L-NAME, N-nitro-l-arginine methyl ester; AS-ODN, antisense oligodeoxynucleotide; MPO,
myeloperoxidase.
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Curiously, results of experiments carried out in vitro renal function against ischemia results from prevention
of sublethal and lethal injury to renal tubular epithelium.and in vivo using l-arginine-based inhibitors of NOS
brought about consistently opposite results: while inhibi- More recently, with the development of a selective
iNOS inhibitor, L-N6-(1-iminoethyl)lysine (L-Nil), wetion of NOS was cytoprotective in vitro, the same inhibi-
tors aggravated ARF in vivo [11–13]. Analyzing the pos- have re-examined the problem and were able to confirm
previous findings [18]. Administration of L-Nil to ratssible reasons for such an apparent discrepancy in results
with NOS inhibition, we argued that the available inhibi- subjected to renal artery cross-clamping ameliorated re-
nal dysfunction.tors of NOS are not selective and/or specific enough [14].
Different types of NOS may differently affect cell viabil- Hence, selective inhibition, depletion or deletion of
iNOS, not affecting constitutive isoforms, clearly demon-ity, as has been demonstrated in mice deficient in neu-
ronal NOS [15]. Therefore, if alternative sources of NO strated its renoprotective effect against ischemia. This
effect was due, at least in part, to the rescue of tubularexert opposite effects, the use of non-selective NOS in-
hibitors may produce ambiguous results. This is probably epithelial cells from injury induced by a product of iNOS.
the case with the results obtained in the in vivo and in
vitro models of acute renal failure [8, 11–13]. While selec-
ROLE OF PEROXYNITRITE IN CELL INJURY
tive inhibitors of NOS isoforms were still in develop-
Generation of reactive oxygen species and nitric oxidemental stages, two other strategies were employed to ad-
in ischemia/reperfusion injury results in formation of adress these problems: AS-ODN and iNOS knockout
cytotoxic metabolite, peroxynitrite, which is capable ofanimals.
causing lipid peroxidation and DNA damage. The studyRecent studies by Ling et al have demonstrated that
was designed to examine the contribution of oxidativeproximal tubules isolated from mice with the targeted
and nitrosative stress to the renal damage in rats withdeletion of iNOS were resistant to hypoxic challenge,
45-minutes of renal artery clamping. This resulted in lipidwhereas the tubular preparations obtained from mice
peroxidation, DNA damage, and nitrotyrosine modifi-lacking eNOS or nNOS were lethally damaged by the
cation, as detected using Western and immunohisto-same degree of hypoxia [16]. These studies strongly sup-
chemical analyses. Animals were randomly treated withport the idea that, despite the shared end-product by all
an inhibitor of inducible NOS (L-Nil), cell-permeablethree enzymes, the sequelae of their activation are vastly
lecithinized superoxide dismutase (SOD), or both. Thedifferent. This is most probably due to the differences
results demonstrated that L-Nil or lecithinized SODin the temporary profile of NO output and the topogra-
treatments improve renal function after renal ischemiaphy of NO release by each NOS.
by suppressing iNOS and oxidative stress, with the com-Results of in vivo application of AS-ODN targeting
bination of agents eliciting a near-correction of renaliNOS further support the role of NO generated by this
dysfunction [18].high-output enzyme in renal injury [17]. Based on results
Having demonstrated the role of anti-oxidative andof studies into the time-course of ODN accumulation by
anti-nitrosative pharmaceuticals (lecithinized SOD andthe proximal tubules, the rats were treated with control
L-Nil, respectively) in ameliorating ischemia-induced re-and experimental ODN constructs eight hours prior to
nal dysfunction, we next designed experiments to directlythe cross-clamping of renal arteries. Administration of
challenge the identity of a noxious product, either super-AS-ODN resulted in a dramatic functional protection
oxide, NO, or peroxynitrite, by utilizing a bona fide per-of kidneys from acute ischemia. The concentration of
oxynitrite scavenger, ebselen. Peroxynitrite scavengingplasma blood urea nitrogen and creatinine in this group
by ebselen shows the second-order rate constant of 2 was not statistically different from sham-operated ani-
106 (mol/L)1 · s1 at pH 7.4 and 37C, exceeding the ratemals and significantly lower than in experimental animals
of peroxynitrite reaction with the natural antioxidantsreceiving sense and scrambled constructs. In sharp con-
like ascorbate or glutathione by approximately three or-trast with the results obtained after selective knock-down
ders of magnitude [19]. On the other hand, the rate ofof iNOS, the use of a non-selective inhibitor of NOS,
peroxynitrite decomposition, after protonation to formN-nitro-l-arginine methyl ester (L-NAME), had no ther-
ONOOH, which can potentially yield approximatelyapeutic effect.
30% of hydroxyl radicals, proceeds with the rate constantTo elucidate the mechanism of protection afforded by
about three orders of magnitude faster than its scaveng-AS-ODN, histological scoring of injury to the nephron
ing [20]. Therefore, efficient scavenging of peroxynitritewas performed. The major registered effects of antisense-
can be achieved only by creating an access of ebselen.ODN were in prevention of tubular necrosis, diminution
It has been demonstrated that ischemic and endotoxin-of the loss of the brush border membrane, and reduction
induced renal injury are accompanied by nitrotyrosinein cast formation. Since both the loss of the brush border
formation [17, 21]. Apart from inhibiting the activity ofand cast formation reflect the degree of tubular cell in-
jury, it can be implied that the AS-ODN protection of several highly susceptible enzymes, that is, prostacyclin
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synthase [22], prostaglandin endoperoxide synthase [23], One of the most striking differences in the NO output
by iNOS as opposed to constitutive forms of this enzymeand Mn-SOD [24], detection of nitrotyrosine-modified
proteins is indicative of the concomitant oxidative and is in the duration of NO release: hours versus minutes.
Cytotoxicity of NO has been linked to the combinednitrosative stress resulting in peroxynitrite formation
[25]. Recently, the uniqueness of peroxynitrite in gener- effects of reduced oxygen intermediates and the back-
ground cellular abundance of antioxidant enzymes. Clem-ating nitrotyrosine residues has been questioned [26].
Therefore, the finding that peroxynitrite scavenger eb- enti et al demonstrated that prolonged, but not short-
term, exposure to NO results in the inhibition of complexselen reduces nitrotyrosine formation in ischemic kid-
neys and improves the functional outcome lends addi- I respiratory chain enzymes leading to the reduction in
cellular concentration of reduced glutathione [29]. Bothtional support to the notion that oxidative and nitrosative
stress occur in this condition in vivo, and are mechanisti- the short-term and prolonged exposure to NO reversibly
inhibit complex IV enzymes, which probably representscally involved in the ensuing loss of kidney function.
These findings establish that reaction (1) physiologic regulation of the respiration. In contrast, per-
sistent inhibition of complex I represents cytotoxic mode
of NO action.
To gain insights into the possibility of suppression of
eNOS by the high-output NO production via iNOS, we
and reaction (2) performed in vivo monitoring of NO release from control
and ischemic kidneys utilizing an NO-selective electro-
chemical technique [17]. Intravenous administration of
bradykinin resulted in an increase of NO release, as judged
by the amplitude of the current, in control rats. In con-
trast, bradykinin had only a marginal effect in kidneys
of ischemic rats. These observations on the blunted NO
release in renal ischemia corroborate the previously re-
ported findings of an absence of vasorelaxation in re-
sponse to endothelium-dependent vasodilators [30]. The
baseline current recorded from ischemic kidneys wasdo take place in renal ischemia-reperfusion: Interest-
higher than that detected in control and AS-ODN–ingly, iNOS per se can be responsible for generation of
treated ischemic kidneys. Furthermore, although pro-products depicted in reaction [1], especially, when l-arg-
foundly suppressed in non-treated ischemic kidneys, theinine becomes depleted in macrophages [27]. Further-
bradykinin-induced elevation in NO release was sparedmore, the presence of SOD may even catalyze the perox-
in AS-ODN–treated animals. These data suggest thatynitrite-induced nitrotyrosine modification of target
the high-output NO production by iNOS may suppressproteins, thus making this particular therapeutic choice
the activity of eNOS (without changing its abundance).somewhat less desirable [24]. Hence, theoretically pre-
Collectively, these and many other observations areferred pathway for limiting oxidative and nitrosative
consistent with the imbalance of NOS function in acutestress could be found in a highly selective inhibition of
renal injury: the activity of the transient-output system,iNOS or scavenging of peroxynitrite, as depicted in Fig-
eNOS, is suppressed, while the activity of the high-outputure 2B.
system, iNOS, is enhanced (Fig. 2C). The functional con-
sequences of such an imbalance could explain some phe-
PATHOPHYSIOLOGIC ROLE OF A DEFECTIVE nomenology of this syndrome, and provide the basis for
eNOS/NO SYSTEM future therapies.
Inhibition of eNOS is one of the hallmarks of the
developing endothelial cell dysfunction, which may ac-
ENDOTHELIAL DYSFUNCTION IN ACUTEcompany some forms of acute renal injury. It has long
RENAL ISCHEMIAbeen known that ischemic kidneys do not respond to
Three decades ago, Flores et al have demonstratedacetylcholine with the decrease in the vascular resistance,
that endothelial cells in the renal vasculature undergorather its increase is detectable [28]. Conger’s observa-
an early swelling leading to the narrowing of the lumention of the lack of responsiveness to acetylcholine in rats
during renal ischemia [31]. This observation was concep-with acute renal failure is one of many examples of poor
tualized in a no-reflow hypothesis [32, 33]. This earlyresponses to endothelium-dependent vasodilators in this
finding has been furthered by the observations that isch-condition [28]. The question is whether this phenomenon
emic renal vasculature is characterized by the profoundis a reflection of inhibition of the enzyme or rather its
maximal stimulation. loss of a vasorelaxing effect of acetylcholine [34]. Conger
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Fig. 3. Schematic representation of endothelial cell transplantation into the ischemic kidney (left) resulting in the improved renal function (right).
et al have demonstrated that vasorelaxation in response IN VIVO INJECTION OF HUVEC IMPROVES
RENAL FUNCTION AFTER RENAL ARTERYto stimuli generating endothelium-derived relaxing fac-
CROSS-CLAMPINGtor was inhibited in acute renal failure (ARF) [28, 30].
In addition, NO production in response to bradykinin was Preliminary studies demonstrated the vulnerability of
found to be suppressed in ischemic kidneys [17]. Over- in vitro, ex vivo and in vivo endothelial cells exposed to
expression of ICAM-1 by the vascular endothelium of pathophysiologically relevant insults, such as oxidative
the ischemic kidney has been demonstrated and neu- and nitrosative stress, or to ischemia (S. Brodsky and
tralizing anti-ICAM-1 antibodies significantly improved M. Goligorsky, unpublished observations). These stimuli
the outcome of renal ischemia [35]. Furthermore, we resulted in the loss of integrity of endothelial layers by
have demonstrated that the endothelium of renal micro- desquamating or retracting cells. We argued that the loss
vessels in ischemic kidneys showed an enhanced expres- of integrity of the endothelial layer, occurring in vivo
sion of RGD-binding integrins [36]. after acute renal ischemia, may lead to the impaired
Collectively, these observations are indicative of endo- vasorelaxation and enhanced vasoconstriction, similar to
thelial cell dysfunction occurring in ARF. If this conclu- that observed by Furchgott and Zawadzki in vascular
sion is correct, it becomes important to examine whether segments with denuded endothelium [37]. Given the pos-
endothelial cell dysfunction is a cause of the tubular sibility that the circulating endothelial cells may home
epithelial cell injury, its consequence, or an independent to the sites of endothelial denudation, athymic nude rats
received a single injection of human umbilical vein endo-variable not affecting the course of ARF.
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